Catheter System Articles & Analysis
39 news found
Among the various materials used in medical device design, polytetrafluoroethylene (PTFE tubing) has emerged as a standout choice, particularly in applications such as catheters and drug delivery systems. This article explores the role of advanced materials like these in driving innovation in medical devices, focusing on their benefits and implications for the ...
Earlier this week, the company received a patent from the Australian Patent Office for its sterilised packaging system for catheters. The patent is for 20 years from July 16, 2018. ...
“The use of the Surfacer System enabled us to quickly and efficiently obtain central venous access after two previous attempts to recanalize the central vein occlusion using other approaches were ...
The AcQForce Flutter trial was designed to evaluate the safety and efficacy of the AcQBlate FORCE sensing ablation catheter and system in the treatment of right atrial typical flutter. Right atrial flutter occurs when rapidly firing electrical signals cause the muscles in the heart’s upper chamber (atria) to contract quickly, leading to a rapid heartbeat ...
“The Surfacer Inside-out system represents a new approach to restore right-sided central venous access in chronic thoracic venous occlusion by the inside-out recanalization technique” stated Dr. ...
The Surfacer System received U.S. FDA De Novo clearance in February 2020. The Centers for Medicare and Medicaid Services (CMS) established a unique Healthcare Common Procedure Coding System (HCPCS) code for procedure associated with the use of the device (C9780) and assigned the procedure to a New Technology APC (1534) effective October 1, 2021 which has a ...
The procedure creates scarring that restores a normal heartbeat. The VX1 system analyzes electrical signals measured during the procedure and identifies abnormalities in real-time. VX1 is versatile and can be installed in most operating rooms and is compatible with the main multipolar catheters and mapping systems. “We are excited by the ...
Using the Surfacer System, we were able to cross the patient’s central venous occlusion and obtain central venous access which facilitated the placement of a Hemodialysis Reliable Outflow (HeRO) graft and removal of their femoral catheter.” “Utilizing the Surfacer System to facilitate gaining central venous access and avoid the ...
The paper, published in the Journal of Vascular Access, demonstrated the ability to gain long-term vascular access without any significant complications or adverse events from the procedure with the benefit of avoiding the placement of a femoral catheter with its associated disadvantages. “This peer-reviewed paper further demonstrates the versatility the Surfacer ...
(Nasdaq: AFIB) (“Acutus”), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the initiation of AcQForce PFA-CE, a new clinical study that will evaluate the safety and performance of the company’s focal force sensing Pulsed Field Ablation (PFA) catheter and system in ...
Recently, Galaxy has also enrolled additional subjects in the ECLIPSE-AF study using the CARTO mapping system and CE-Marked catheters manufactured by Biosense Webster, achieving CENTAURI compatibility with the three market leading cardiac mapping systems and their associated catheters. ...
Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today that the Centers for Medicare & Medicaid Services (CMS) has finalized a new Healthcare Common Procedure Coding System (HCPCS) code and New Technology Ambulatory Payment Classification ...
The company’s portfolio comprises two core products, the Walrus Balloon Guide Catheter (BGC) system, and the Wahoo Control™ Catheter hybrid access system. ...
Q’Apel’s portfolio comprises three products, the Walrus Balloon Catheter System, the Wahoo Hybrid Access System and Armadillo Radial Access System. Before Walrus came along, balloon-based variable stiffness catheters brought all manner of technological constraints. Not anymore. By blending flow ...
“We are pleased to see that a complete persistent AF ablation performed in the EP lab by one electrophysiologist using only one catheter achieves outcomes superior to more logistically complex procedures,” said Dr. ...
Also, the company has recently treated patients in the same study using CE-Marked catheters and mapping systems from Boston Scientific, Biosense Webster and Abbott. ...
The company’s portfolio comprises two core products, the Walrus Balloon Guide Catheter (BGC) system, and the Wahoo Control™ Catheter hybrid access system. ...
The ECLIPSE-AF Trial launched in September 2020 to study the acute safety of Galaxy’s flagship CENTAURI™ system, which uses Pulsed Electric Field (PEF) technology to treat cardiac arrhythmias. ...
Q’Apel Medical products are currently being utilized in over 160 hospital systems nationwide. About Q’Apel Medical: Q’Apel Medical designs highly innovative technologies for vascular interventions and unmet clinical needs. Q’Apel’s core portfolio comprises two products, the Walrus Balloon Catheter System and the ...
The ECLIPSE-AF Trial launched in September 2020 to study the acute safety of Galaxy’s flagship CENTAURI™ System, which uses Pulsed Electric Field (PEF) technology to treat cardiac arrhythmias. ...